233 related articles for article (PubMed ID: 30031098)
1. Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs.
Cloutier J; Thompson ED; Cimino-Mathews A; Rooper LM; Matoso A; Argani P
Hum Pathol; 2018 Dec; 82():76-86. PubMed ID: 30031098
[TBL] [Abstract][Full Text] [Related]
2. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D
Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358
[TBL] [Abstract][Full Text] [Related]
3. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
Ding HY; Gao LX
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
[TBL] [Abstract][Full Text] [Related]
4. Metastatic gastrinoma in the breast mimicking primary solid papillary carcinoma.
Burt M; Madan R; Fan F
Hum Pathol; 2016 Oct; 56():143-6. PubMed ID: 27342908
[TBL] [Abstract][Full Text] [Related]
5. Utility of Sox10 labeling in metastatic breast carcinomas.
Nelson ER; Sharma R; Argani P; Cimino-Mathews A
Hum Pathol; 2017 Sep; 67():205-210. PubMed ID: 28843711
[TBL] [Abstract][Full Text] [Related]
6. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?
Helpap B; Köllermann J
Virchows Arch; 2001 Jan; 438(1):86-91. PubMed ID: 11213840
[TBL] [Abstract][Full Text] [Related]
9. An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.
Yu S; Hornick JL; Gonzalez RS
Virchows Arch; 2021 Sep; 479(3):481-491. PubMed ID: 33733343
[TBL] [Abstract][Full Text] [Related]
10. [Breast carcinoma with predominant neuroendocrine differentiation].
Frachon S; Pasquier D; Treilleux I; Seigneurin D; Ringeisen F; Rosier P; Bolla M; Boutonnat J
Ann Pathol; 2004 Jun; 24(3):278-83. PubMed ID: 15480266
[TBL] [Abstract][Full Text] [Related]
11. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?
Koo J; Dhall D
Semin Diagn Pathol; 2015 Nov; 32(6):456-68. PubMed ID: 26573790
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
Seijnhaeve E; Galant C; Van Bockstal MR
Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
[TBL] [Abstract][Full Text] [Related]
14. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.
Matias-Guiu X; LaGuette J; Puras-Gil AM; Rosai J
Am J Surg Pathol; 1997 Jul; 21(7):754-62. PubMed ID: 9236831
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of neuroendocrine carcinoma of the breast.
Sapino A; Papotti M; Righi L; Cassoni P; Chiusa L; Bussolati G
Ann Oncol; 2001; 12 Suppl 2():S115-7. PubMed ID: 11762336
[TBL] [Abstract][Full Text] [Related]
16. Unusual apocrine carcinoma with neuroendocrine differentiation: a cutaneous neoplasm may be analogous to neuroendocrine carcinoma with apocrine differentiation of breast.
Li Y; Chen LL; Li B; Tian XY; Li Z
Diagn Pathol; 2015 Jun; 10():64. PubMed ID: 26055980
[TBL] [Abstract][Full Text] [Related]
17. [Neuroendocrine neoplasms of the breast].
Anlauf M; Neumann M; Bomberg S; Luczak K; Heikaus S; Gustmann C; Antke C; Ezziddin S; Fottner C; Pavel M; Pape UF; Rinke A; Lahner H; Schott M; Cremer B; Hörsch D; Baum RP; Groh U; Alkatout I; Rudlowski C; Scheler P; Zirbes TK; Hoffmann J; Fehm T; Gabbert HE; Baldus SE
Pathologe; 2015 May; 36(3):261-70. PubMed ID: 25986886
[TBL] [Abstract][Full Text] [Related]
18. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
Zheng G; Ettinger DS; Maleki Z
Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
[TBL] [Abstract][Full Text] [Related]
19. Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity.
Amin M; Trikalinos N; Chatterjee D
Hum Pathol; 2021 Aug; 114():36-43. PubMed ID: 33891968
[TBL] [Abstract][Full Text] [Related]
20. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".
Braxton DR; Saxe D; Damjanov N; Stashek K; Shroff S; Morrissette JD; Tondon R; Furth EE
Hum Pathol; 2017 Apr; 62():232-241. PubMed ID: 28232156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
